Skip to Main Content

Paper Details

TNF-Blockade for Primary Stroke Prevention in Adenosine Deaminase 2 Deficiency: A Case Series.
Neurol Neuroimmunol Neuroinflamm
1
2023
Adenosine, Adenosine Deaminase 2, Adenosine Deaminase 2 Deficiency, Adenosine deaminase 2, Adenosine deaminase 2 deficiency, DADA2, Stroke, TNF, children, cryptogenic stroke, cryptogenic strokes, genetic sequence variant, patient, patients, primary, stroke, strokes, systemic vasculitis syndrome, tumor necrosis factor
Author NameAffiliation
Ariane SoldatosFrom the National Institute of Neurological Disorders and Stroke (A.S.) National Human Genome Research Institute (C.T., and Blood Institute
Camilo ToroFrom the National Institute of Neurological Disorders and Stroke (A.S.) National Human Genome Research Institute (C.T., and Blood Institute
Daniel L KastnerFrom the National Institute of Neurological Disorders and Stroke (A.S.) National Human Genome Research Institute (C.T., and Blood Institute
  • 1 - 3

Datasets

Release 1.2